Open Label Extension Study to Assess the Safety and Long-Term Immunogenicity of ARCT-021
Clinical trial NCT04728347 · TERMINATED
Trial details
- NCT number
- NCT04728347
- Sponsor
- Arcturus Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-04
- Primary completion
- 2021-12-28
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.